Suppr超能文献

人组织因子途径抑制物的第二个Kunitz结构域:克隆、结构测定及与因子Xa的相互作用

The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.

作者信息

Burgering M J, Orbons L P, van der Doelen A, Mulders J, Theunissen H J, Grootenhuis P D, Bode W, Huber R, Stubbs M T

机构信息

Scientific Development Group, N.V. Organon, Oss, The Netherlands.

出版信息

J Mol Biol. 1997 Jun 13;269(3):395-407. doi: 10.1006/jmbi.1997.1029.

Abstract

Tissue Factor Pathway Inhibitor (TFPI) is a 36 kDa glycoprotein that helps maintain haemostasis by inhibiting Factor Xa and the Factor VIIa/Tissue Factor (TF) complex. TFPI contains three tandemly linked Kunitz inhibitor domains, of which the second inhibits factor Xa. We have undertaken a multidisciplinary approach to study the structure and function of the second Kunitz domain of TFPI, with a view towards the rational design of factor Xa inhibitors. Amino acid residues 93 to 154 of the mature TFPI protein, corresponding to the second Kunitz domain (TFPI-kII), were expressed in Escherichia coli. The protein was purified to near homogeneity by ion exchange, hydrophobic interaction, and size exclusion chromatography, respectively. TFPI-kII is a potent factor Xa inhibitor with a Ki of 1.5 x 10(-10) M, a value that does not differ significantly from that of intact TFPI. The three-dimensional structure of TFPI-kII in aqueous solution was determined by 1H nuclear magnetic resonance spectroscopy (NMR). A set of 30 conformers was calculated with the program DIANA using 906 distance constraints derived from nuclear Overhauser effects and 23 dihedral angle constraints. This set, representing the solution structure of TFPI-kII, has an average root-mean-square deviation of 0.78 A for the backbone atoms and 1.38 A for all heavy atoms of residues 1 to 58. The structure of TFPI-kII has also been determined in complex with porcine trypsin using X-ray crystallographic techniques. The complex has been solved to a resolution of 2.6 A, with a final R-factor of 16.2%. Comparison of the NMR derived structure with that of TFPI-kII in complex with trypsin reveals little divergence of the two structures, with the exception of residue Tyr17. Superposition of the trypsin:TFPI-kII complex on factor Xa provides insights into macromolecular determinants for the inhibition of factor Xa. Complexation would require a degree of reorganisation of factor Xa residues, in particular of TyrF99, but also perhaps of the F148-loop. The interaction was further investigated using restrained molecular dynamics. Electrostatic interactions would appear to play a major role. The reorganisation of factor Xa is in contrast to the proposed factor Xa:TAP interaction, where TAP would bind to the "ground state" structure of factor Xa.

摘要

组织因子途径抑制物(TFPI)是一种36 kDa的糖蛋白,它通过抑制因子Xa以及因子VIIa/组织因子(TF)复合物来维持止血功能。TFPI包含三个串联的Kunitz抑制结构域,其中第二个结构域可抑制因子Xa。我们采用多学科方法研究TFPI第二个Kunitz结构域的结构与功能,旨在合理设计因子Xa抑制剂。成熟TFPI蛋白的第93至154位氨基酸残基,对应于第二个Kunitz结构域(TFPI-kII),在大肠杆菌中表达。该蛋白分别通过离子交换、疏水相互作用和尺寸排阻色谱法纯化至近乎同质。TFPI-kII是一种有效的因子Xa抑制剂,其Ki为1.5×10⁻¹⁰ M,该值与完整TFPI的值无显著差异。通过¹H核磁共振光谱(NMR)测定了TFPI-kII在水溶液中的三维结构。使用程序DIANA,根据源自核Overhauser效应的906个距离约束和23个二面角约束计算出一组30个构象体。这组构象体代表了TFPI-kII的溶液结构,对于第1至58位残基的主链原子,其平均均方根偏差为0.78 Å,对于所有重原子为1.38 Å。还使用X射线晶体学技术确定了TFPI-kII与猪胰蛋白酶复合物的结构。该复合物的分辨率为2.6 Å,最终R因子为16.2%。将NMR推导的结构与TFPI-kII与胰蛋白酶复合物的结构进行比较,发现除了Tyr17残基外,这两种结构几乎没有差异。将胰蛋白酶:TFPI-kII复合物叠加在因子Xa上,为抑制因子Xa的大分子决定因素提供了见解。形成复合物需要因子Xa残基进行一定程度的重新排列,特别是TyrF99,也许还有F148环。使用受限分子动力学进一步研究了这种相互作用。静电相互作用似乎起主要作用。因子Xa的重新排列与所提出的因子Xa:TAP相互作用形成对比,在该相互作用中,TAP会结合到因子Xa的“基态”结构上。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验